| Unique ID issued by UMIN | UMIN000015895 |
|---|---|
| Receipt number | R000018502 |
| Scientific Title | Drug Use-results survey for Simponi 50mg |
| Date of disclosure of the study information | 2014/12/15 |
| Last modified on | 2019/03/06 10:53:51 |
Drug Use-results survey for Simponi 50mg
Drug Use-results survey for Simponi 50mg
Drug Use-results survey for Simponi 50mg
Drug Use-results survey for Simponi 50mg
| Japan |
Rheumatoid Arthritis
| Clinical immunology | Orthopedics |
Others
NO
Confirm the safety and efficacy of Simponi in the patients with Rheumatoid arthritis
Safety,Efficacy
Safety (Adverse Drug Reaction)
Effectiveness (Disease Activity Score 28, Visual Analog Scale)
Observational
| Not applicable |
| Not applicable |
Male and Female
Patients with rheumatoid arthritis who are treated with Simponi
NA
3000
| 1st name | |
| Middle name | |
| Last name | Toshiya Kato |
Janssen Pharmaceutical K.K.
Safety Risk Management Dept.
5-2, Nishi-Kanda 3chome, Chiyoda-ku, Tokyo
03-4411-5017
tkato1@its.jnj.com
| 1st name | |
| Middle name | |
| Last name | Akiko Yamamoto |
Janssen Pharmaceutical K.K.
Safety Risk Management Dept.
5-2, Nishi-Kanda 3chome, Chiyoda-ku, Tokyo
03-4411-5173
ayamamot@its.jnj.com
Janssen Pharmaceutical K.K.
Janssen Pharmaceutical K.K.
Profit organization
NO
| 2014 | Year | 12 | Month | 15 | Day |
Published
Completed
| 2011 | Year | 08 | Month | 05 | Day |
| 2011 | Year | 09 | Month | 16 | Day |
Prospective study
| 2014 | Year | 12 | Month | 10 | Day |
| 2019 | Year | 03 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018502